В.А. Золотцев

1. V. A. Zolottsev,Ya. V. Tkachev, A. S. Latysheva, V. A. Kostin, R. A. Novikov, V. P. Timofeev, G. E. Morozevich, A. V. Kuzikov, V. V. Shumyantseva, A. Y. Misharin Comparison of [17(20)E]-21-Norpregnene oxazolinyl and benzoxazolyl derivatives as inhibitors of CYP17A1 activity and prostate carcinoma cells growth.  Steroids (2018), Vol. 129, pp 24–34. 

2. A. S. Latysheva, V. A. Zolottsev, A. V. Veselovsky, K. A. Scherbakov, G. E. Morozevich, V. S. Pokrovsky,  R. A. Novikov, V. P. Timofeev, Y. V. Tkachev, A. Y. Misharin New Steroidal Oxazolines,Benzoxazoles and Benzimidazoles Related to Abiraterone and Galeterone, Steroids (2020), Vol. 153, P. 108534 

3. Pokrovsky V.S., Zolottsev V.A., Latysheva A.S., Kudinov V.A., Anisimova N.Yu., Almanza R.L.M., Alekseeva O.Yu., Baskaev K.K., Smirnova G.B., Borisova Yu.A., Ipatova O.M., Alsevirone-NF Reduces Serum Testosterone and Inhibits Prostate Cancer Xenograft Growth in Balb/c Nude Mice, Clinical Cancer Drugs, 2020, Vol. 7, P. 1-6

4. A. S. Latysheva, V. A. Zolottsev, V. S. Pokrovsky*, I. I. Khan and A. Yu. Misharin, “Novel nitrogen containing steroid derivatives for prostate cancer treatment”, Current Medicinal Chemistry (2021) 28: 1.  doi: 10.2174/0929867328666210208113919

5. .V. А. Zolottsev, А. S. Latysheva, V. S. Pokrovsky, I. I. Khan, A. Y. Misharin,Promising applications of steroid сonjugates for cancer research and treatment, European Journal of Medicinal Chemistry, Volume 210, 2021, 113089.